Financial News
Latest News about ALKS
Recent news which mentions ALKS
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
February 08, 2022
Tickers
ALKS
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
From Benzinga
BioCorRx Aims To Help Combat Opioid Crisis With Implantable Naltrexone Drug Candidate BICX104
January 24, 2022
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
December 01, 2021
From Benzinga
Direxion Launches New Nanotechnology ETF, TYNE
November 23, 2021
From ETF Trends
75 Biggest Movers From Yesterday
November 10, 2021
From Benzinga
From Benzinga
Why Alkermes Stock Is Sinking Today
November 09, 2021
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
7 A-Rated Healthcare Stocks to Buy for the Long Haul
November 01, 2021
Tags
PRTA
NASDAQ:BNTX,NASDAQ:JYNT,NASDAQ:BRKR,NASDAQ:HSKA,NASDAQ:PRTA,NASDAQ:INMD,NASDAQ:ALKS,NYSE:PFE
Market News
From InvestorPlace
10 Biggest Price Target Changes For Thursday
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
3 Mid-Cap Stocks With Large-Cap Potential
October 15, 2021
From InvestorPlace
2 Supercharged Stocks Near 52-Week Highs Despite the Market Pullback
October 13, 2021
From Motley Fool
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Benzinga's Bulls And Bears Of The Week: Alibaba, Apple, Nio, PayPal, Verizon And More
September 04, 2021
From Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
September 02, 2021
Tickers
ALKS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
September 02, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
